Magnetic Stimulation Therapy for Treating Vascular Depression
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
This 12-week study will evaluate the effectiveness of repetitive transcranial magnetic
stimulation (rTMS) of the brain, followed by citalopram (Celexa®), for treatment of
depression associated with small vascular lesions in the brain (vascular depression).